Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform (2023)

First Author: Zheng B
Attributed to:  Phase 1 COVID-19 Longitudinal Health and Wellbeing - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.lanepe.2023.100741

PubMed Identifier: 37927438

Publication URI: http://europepmc.org/abstract/MED/37927438

Type: Journal Article/Review

Parent Publication: The Lancet Regional Health - Europe